BorderFolio/Irish-domiciled ETF alternatives/VXUS
VXUS Irish-domiciled alternative: UCITS options for non-US investors
Last reviewed 27 September 2026
VXUS is a popular way to own developed and emerging markets outside the United States in a single fund. For a non-US investor looking for an Irish-domiciled UCITS version, the answer is less straightforward than it is for an S&P 500 fund: there is no one-fund VXUS clone. This page sets out the UCITS routes that do exist, what each actually holds, and the one detail that decides whether a two-fund replacement has a hole in it.
Quick answer. No exact Irish-domiciled UCITS equivalent of VXUS exists. No UCITS ETF tracks its index, FTSE Global All Cap ex US.
The closest route depends on what you actually want:
Developed markets outside the US — one fund: an MSCI World ex USA UCITS ETF (EXUS, IXUA or WEXU). Developed plus emerging — two funds: one of those plus an emerging-market UCITS ETF. A single fund for simplicity — a global UCITS fund such as VWRA, but it includes the United States and is therefore not a VXUS substitute. The closest possible recreation — the two-fund route, matching index families, accepting that developed ex-US small caps have no clean UCITS building block.
On this page
What VXUS actually holds
VXUS is not "international developed markets", and it is not "Europe". The Vanguard Total International Stock ETF tracks the FTSE Global All Cap ex US Index, which Vanguard describes as covering 98% of the world's non-US markets. As of 30 June 2026 the fund held 8,755 stocks at an expense ratio of 0.05%, distributing quarterly.
Three things are bundled into that one ticker, and it is the bundle that makes a UCITS replacement awkward:
- Everything except the United States. Developed Europe, Japan, Canada, Australia and the rest.
- Emerging markets. China, India, Brazil and others sit in the same fund, not in a separate sleeve.
- All market caps. Large, mid and small, which is where most of those 8,755 lines come from.
Vanguard's ten largest market allocations as of 30 June 2026 show the mix directly: Japan 15.4%, Taiwan 9.1%, United Kingdom 8.0%, Canada 7.7%, Korea 7.5%, China 6.7%, Switzerland 5.1%, France 5.1%, Germany 4.6%, India 4.4%. Those weights move with market capitalisation and are a snapshot, not a fixed allocation.
The detail that decides everything below. FTSE classifies South Korea as a developed market. MSCI classifies it as an emerging one. VXUS follows a FTSE index, so Korea — 7.5% of the fund at the date above — arrives inside its developed allocation. Every mainstream UCITS ex-US building block follows MSCI, where Korea does not. Which partner fund you pick decides whether Korea is in your portfolio at all.
The UCITS candidates, side by side
Every fund below is Irish-domiciled and UCITS. None of them tracks VXUS's index; they are building blocks that cover part of what VXUS covers.
| Fund | Index | Domicile | EM? | Class | Charge | How close to VXUS? |
|---|---|---|---|---|---|---|
| VXUS Vanguard Total International Stock |
FTSE Global All Cap ex US Dev + EM, all caps |
United States | Yes | Dist. | 0.05% | The reference |
| EXUS Xtrackers · IE0006WW1TQ4 |
MSCI World ex USA Developed, large + mid |
Ireland | No | Acc. | 0.15% | Developed half only — no Korea, no small caps |
| IXUA iShares · IE000R4ZNTN3 |
MSCI World ex USA Developed, large + mid |
Ireland | No | Acc. | 0.15% | Same exposure as EXUS, different issuer |
| WEXU Amundi · IE00085PWS28 |
MSCI World ex USA Developed, large + mid |
Ireland | No | Acc. | 0.15% | Same again — smallest of the three by assets |
| EIMI iShares Core · IE00BKM4GZ66 |
MSCI EM IMI Emerging, incl. small caps |
Ireland | EM only | Acc. | 0.18% | Partner fund — holds Korea |
| VFEM Vanguard · IE00B3VVMM84 dist IE00BK5BR733 acc |
FTSE Emerging Emerging, large + mid |
Ireland | EM only | Both | 0.17% | Partner fund — holds no Korea |
Fund data as published by the issuers and by fund data providers in September 2026; VXUS figures from Vanguard's factsheet as of 30 June 2026. Ongoing charges, share classes, holdings and index memberships change — the factsheet is the authority, not this page.
Option 1 — developed markets outside the US
If what you actually want is developed markets outside the United States, one fund does it. Three Irish-domiciled UCITS ETFs track MSCI World ex USA, all accumulating, all at a 0.15% ongoing charge as published in September 2026: Xtrackers EXUS (around 755 holdings, the largest of the three by assets and the oldest, launched March 2024), iShares IXUA (around 751 holdings, launched January 2025) and Amundi WEXU (launched September 2024). They hold the same index, so the choice between them is about fund size, spreads and issuer rather than exposure.
Against VXUS, here is what one of those funds gives you and what it does not:
| Exposure | VXUS | MSCI World ex USA UCITS fund |
|---|---|---|
| Developed markets ex-US, large and mid cap | Yes | Yes |
| South Korea | Yes — 7.5% at 30 Jun 2026, as a developed market | No — MSCI treats it as emerging |
| Emerging markets | Yes | No |
| Developed ex-US small caps | Yes | No — large and mid cap only |
Two of those gaps are the ones people expect. The Korea line is the one that catches readers out, because it is missing from a fund whose name promises "developed markets" — Korea is developed in the index family VXUS uses, and is not in the family the UCITS funds use.
Option 2 — developed ex-US plus emerging markets
The closest available recreation of VXUS's role is two funds: a developed ex-US fund and an emerging-market fund, held alongside each other.
Important difference: match the index families. An MSCI World ex USA fund paired with an MSCI emerging-market fund such as EIMI covers developed and emerging markets with no gap, because Korea sits in the emerging leg — EIMI's country breakdown showed South Korea at about 19.9%, its second-largest country.
The same MSCI developed fund paired with a FTSE emerging-market fund such as VFEM leaves Korea in neither: FTSE calls it developed, so it is absent from FTSE Emerging, and MSCI calls it emerging, so it is absent from MSCI World ex USA. Two sensible funds, one country-shaped hole worth roughly the weight VXUS gives it.
The emerging-market building blocks differ in more than Korea. EIMI follows MSCI Emerging Markets IMI, where IMI means the index reaches down into small caps; its published country breakdown ran Taiwan 27.3%, South Korea 19.9%, China 17.0%, India 12.5%. VFEM follows FTSE Emerging, large and mid cap, with Taiwan 32.5%, China 24.6%, India 15.6%, Brazil 4.2%. Both are Irish-domiciled; VFEM exists in distributing and accumulating classes, EIMI is accumulating.
What the two-fund route still does not recover is developed ex-US small caps. MSCI World ex USA is a large and mid cap index, and the mainstream UCITS range has no developed-ex-US small-cap fund to bolt on — the widely held small-cap UCITS ETF, iShares MSCI World Small Cap (IE00BF4RFH31), includes the United States and so reintroduces exactly the exposure VXUS was chosen to exclude.
On weights: VXUS carries whatever split between developed and emerging the index produces, and it rebalances itself. Two funds do not. You choose the ratio, and you maintain it — which is a portfolio decision, not a fund-selection one, and one this page deliberately does not make for you. Market capitalisations move, so any split quoted today is a snapshot rather than a target.
Option 3 — one global fund instead
Some readers arriving at this question are solving a different problem than the one they have typed. If the real objective is "international diversification without holding US-domiciled ETFs" rather than "the non-US part specifically", then a single global UCITS fund is operationally simpler than any combination above — one holding, one rebalancing problem solved by the index.
Single-fund alternative — but read the difference. VWRA tracks FTSE All-World, which includes the United States, normally as the largest single country weight. VXUS excludes it. They are not substitutes, and swapping one for the other changes your US allocation rather than your wrapper.
If whole-world exposure is what you want, the head-to-head is on VT vs VWRA. If you hold a US fund separately and want the rest of the world beside it, stay on this page.
The same logic runs the other way for anyone holding a US-market fund already: VXUS, or a UCITS ex-US block, is the complement to it. The VTI page covers the US side of that pair, which has its own missing-clone problem.
Why non-US investors look for Irish-domiciled funds
The reason to prefer the UCITS route has little to do with what the funds hold, and the weight of each reason depends on where you live.
- Availability. Retail brokers in the EEA and the UK generally decline US-domiciled ETFs, because those funds do not publish the Key Information Document that PRIIPs requires. For many readers this settles the question before anything else does.
- US estate situs. A US-domiciled fund is a US-situs asset. For a non-US, non-resident estate, US-situs holdings above USD 60,000 can attract US estate tax unless an estate tax treaty raises that threshold, and the US has estate treaties with relatively few countries. An Irish-domiciled UCITS is not a US-situs asset for this purpose.
- Dividend withholding. A US fund's distribution is US-source income taxed at your own treaty rate; an Irish fund suffers withholding inside the fund on the US dividends it receives. For an ex-US fund this layer matters far less than it does for a US-equity fund, because most of the underlying dividends are not US-source in the first place. Your residence's rate is a published number.
- Accumulating share classes. Every UCITS fund named on this page has one; VXUS distributes. Whether that helps or hurts is residence-specific — some countries tax accumulating funds on a deemed basis regardless.
None of this is a universal rule. Tax outcomes depend on your residence, your treaty position and your own circumstances. The mechanics behind all four points are set out in US ETFs vs Irish UCITS, and the assumptions behind the estimates in the withholding methodology.
VXUS against the UCITS route
| VXUS | UCITS route | |
|---|---|---|
| In its favour | One fund. Developed and emerging, large through small, rebalanced by the index. 0.05%. | UCITS structure, Irish domicile, accumulating classes available, and no US-situs exposure from the wrapper itself. |
| Against it | US domicile, with the estate and availability consequences above. Often simply not purchasable by EEA and UK retail investors. | No exact clone. One fund covers developed only; matching VXUS's breadth takes two. Different index family, so different country classification. Developed small caps have no clean building block. |
| Cost, as published Sept 2026 | 0.05% | 0.15% for the developed leg; 0.17–0.18% for an emerging leg |
The cost gap is real and it is the honest count against the UCITS route on this particular exposure — wider in relative terms than it is for S&P 500 funds, where a UCITS fund can match or undercut the US original. Whether it outweighs availability and estate treatment is not a question arithmetic answers on its own.
If you already hold both sides
Anyone moving from a US-domiciled fund to a UCITS equivalent ends up holding the old position and the new one for a while, often across two brokers and two currencies, with a contribution history spanning the change. A two-fund replacement makes it harder still: your actual developed-versus-emerging split becomes something you compute rather than read off a line, and withholding suffered inside a UCITS fund never appears on a statement at all. BorderFolio estimates that per instrument from the domicile of each fund you actually hold against the tax residence you configure, on your real dividend history rather than a worked example.
Limitations
- This page compares structures, it does not recommend one. Naming the funds that track an index is not a view on whether you should hold them, and no allocation between them is suggested here.
- Country weights are a snapshot. Every percentage quoted is dated and moves with market capitalisation. Korea's 7.5% of VXUS is its weight at 30 June 2026, not a constant.
- Index membership can change. Country classifications are reviewed periodically by both FTSE and MSCI. The Korea split described here is the position as published in September 2026.
- Fund data ages. Ongoing charges, share classes, holdings counts and listings are as published in September 2026. The factsheet is the authority.
- The tax layer is residence-specific. What your own country charges, whether it credits foreign withholding, and how it treats accumulating funds are not modelled here.
- Not advice. This is an informational comparison of fund structures, not a recommendation to buy or sell any of them. See the investment & tax disclaimer.
Common questions
Is there an Irish-domiciled equivalent of VXUS?
There is no exact one. No UCITS ETF tracks the FTSE Global All Cap ex US Index that VXUS follows, and no single Irish-domiciled fund reproduces its combination of developed markets, emerging markets and small caps outside the United States. The closest single building block is an MSCI World ex USA UCITS ETF, which covers developed markets only, at large and mid cap. Adding an emerging-market UCITS ETF alongside it recovers most of what is missing.
What is the UCITS equivalent of VXUS?
There is no index-for-index equivalent. Three Irish-domiciled UCITS ETFs track MSCI World ex USA and are the nearest single funds: Xtrackers EXUS (IE0006WW1TQ4), iShares IXUA (IE000R4ZNTN3) and Amundi WEXU (IE00085PWS28), all accumulating and all with a 0.15% ongoing charge as published in September 2026. None of them holds emerging markets, so none of them is a VXUS substitute on its own.
Is EXUS the same as VXUS?
No. EXUS is the Xtrackers MSCI World ex USA UCITS ETF, an Irish-domiciled accumulating fund tracking developed markets outside the United States at large and mid cap — around 755 holdings. VXUS tracks FTSE Global All Cap ex US, which adds emerging markets and small caps and held 8,755 stocks as of 30 June 2026. EXUS is a developed-markets building block, not a VXUS clone.
Does a developed-world-ex-US ETF replace VXUS?
Only partly. It covers the developed half and leaves out emerging markets entirely. Because MSCI classifies South Korea as an emerging market while FTSE classifies it as developed, an MSCI World ex USA fund also leaves out South Korea, which was 7.5% of VXUS as of 30 June 2026. Developed small caps are missing too, since MSCI World ex USA is a large and mid cap index.
How can UCITS investors get emerging-market exposure?
Through an Irish-domiciled emerging-market UCITS ETF. Two mainstream options are the iShares Core MSCI EM IMI UCITS ETF (EIMI, IE00BKM4GZ66, 0.18%, accumulating), which follows MSCI Emerging Markets IMI and includes small caps, and the Vanguard FTSE Emerging Markets UCITS ETF (IE00B3VVMM84 distributing, IE00BK5BR733 accumulating, 0.17%), which follows FTSE Emerging. The two indices disagree about South Korea, which matters when choosing a partner fund.
Is VWRA an alternative to VXUS?
Not to VXUS specifically. VWRA is an Irish-domiciled UCITS fund tracking FTSE All-World, which includes the United States — typically the largest single country weight in the index. VXUS deliberately excludes the US. If the goal is whole-world equity exposure in a UCITS wrapper, VWRA is a simpler single fund; if the goal is specifically the non-US part, it is the wrong instrument.
Why might a non-US investor avoid US-domiciled VXUS?
Three reasons, which apply differently to different people. Availability: retail brokers in the EEA and the UK decline US-domiciled ETFs because they do not publish a PRIIPs Key Information Document. Estate exposure: US-domiciled funds are US-situs assets, and a non-US, non-resident estate holding more than USD 60,000 of them can face US estate tax unless a treaty raises that threshold. Dividend withholding: the treatment differs between a US fund and an Irish one, and the outcome depends on your residence and treaty position. None of this is universal — it depends on where you live.
Can I recreate VXUS with two UCITS ETFs?
You can get close, provided both funds come from the same index family. An MSCI World ex USA fund paired with an MSCI emerging-market fund covers developed and emerging markets without a gap, because South Korea sits in the emerging leg. Pairing an MSCI World ex USA fund with a FTSE emerging-market fund leaves South Korea in neither, since FTSE treats it as developed and MSCI does not. What no two-fund combination fully recovers is developed ex-US small caps, and the weights between the two funds are yours to set and rebalance rather than an index's.